Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.084 | Clinical Characteristics, Anticholinergic Burden, Treatment Patterns, and Drug Persistence in Patients with Overactive Bladder in Hong Kong: A Real-World Observational Study |
Prof. NG Chi Fai 吳志輝 |
| 2023.085 | Association between nephrolithiasis and future cardiovascular events: a population-based analysis of patients utilizing public health systems in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2022.394 | Elucidating the functional role of exosomal protein LRG1 and its clinical implication in castration-resistant prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2020.603 | To investigate the role of gut microbiome in androgen deprivation therapy related metabolic changes in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2021.506 | To investigate the effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy | Prof. NG Chi Fai |
| 2020.611 | To identify potential new urine marker panel for cancer screening |
Prof. NG Chi Fai 吳志輝 |
| 2022.576 | A retrospective study of the urinary stone composition and its epidemiological and clinical association in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2021.675 | Development of luminescent nanobiosensor for bladder cancer miRNA detection |
Prof. NG Chi Fai 吳志輝 |
| 2022.244 | The use of temporarily implanted nitinol device (iTind) system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2020.454 | A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of novel anti-hormonal therapy (NAH) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of NAH |
Prof. NG Chi Fai 吳志輝 |
| 2021.684 | A prospective assessment of the perioperative parameter and treatment outcomes of urinary calculi – international registry |
Prof . NG Chi Fai 吳志輝 |
| 2022.560 | To study the effect of baseline testosterone level on prognosis in Asian patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2021.687 | Surgical PRODUCT SURVEILLANCE REGISTRY (PSR) PLATFORM BASE & Medtronic Hugo™ RAS System General Surveillance in Hong Kong Product Surveillance Registry (PSR) Platform Analysis Plan |
Prof. NG Chi Fai 吳志輝 |
| 2018.063 | To investigate the diagnostic accuracy of exosomal microRNA in predicting the aggressiveness of prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2018.541 | SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.662 | The use of REZUM system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2019.166 | A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma |
Prof. NG Chi Fai 吳志輝 |
| 2020.050 | To evaluate the performance of a urine spermine measuring device in predicting prostate biopsy result |
Prof. NG Chi Fai 吳志輝 |
| 2019.211 | To establish a reproducible organoid culture model with human kidney cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.276 | A prospective randomized study to investigate the effect of extracorporeal shockwave lithotripsy on blood pressure control in patients with hypertension – a pilot study |
Prof. NG Chi Fai 吳志輝 |
| 2018.280 | A cross sectional study to assess the effect of androgen deprivation therapy on Gut and Urinary Microbiota in patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.378 | To identify potential new genetic marker for diagnosis of cystinuria. |
Prof. NG Chi Fai 吳志輝 |
| 2018.323 | Can transperineal prostate biopsy replace transrectal prostate biopsy? Hong Kong experience of the first 100 cases of transperineal prostate biopsy |
Prof. NG Chi Fai 吳志輝 |
| 2019.017 | To investigate the possible underlying causes for patient with nocturia in Hong Kong patients |
Prof. NG Chi Fai 吳志輝 |
| 2019.400 | A retrospective review of the association of baseline characteristics of male patients presented with lower urinary tract and long term clinical outcomes |
Prof. NG Chi Fai 吳志輝 |
| 2019.491 | Patient Preference of Apalutamide versus Enzalutamide in Patients with Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial. (version 1.0) |
Prof. NG Chi Fai 吳志輝 |
| 2018.376 | To identify potential new urine markers for the screening of prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2020.185 | To compare Spermine Risk Score and Prostate Health Index in diagnosing prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2020.058 | Characterising and Fingerprinting Biomarkers of Urolithiasis: A Case Control Study |
Prof. NG Chi Fai 吳志輝 |
| 2019.534 | To investigate the effect of central arterial stiffness on the progression of male bladder dysfunction, nocturia and lower urinary tract symptoms |
Prof. NG Chi Fai 吳志輝 |
| 2017.583 | The Investigation of the use of canines in the detection of prostate cancer |
Dr. NG Chi Fai 吳志輝 |
| 2025.427 | A Phase II trial on Fezolinetant for vasomotor symptoms in men receiving androgen deprivation therapy (ADT) for prostate cancer (Fez-Cap) | Prof. NG Chi Fai |
| 2024.217 | A Randomized Controlled Trial Comparing Robotic Flexible Ureteroscopy with Standard Flexible Ureteroscopy for Treatment of Renal Stones – A Pilot Study | Prof. NG Chi Fai |
| 2025.414 | DISON I Study (Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis - A First-In-Human Study) | Prof. NG Chi Fai |
| 2024.600 | A prospective randomized study to investigate the effect of pulsed electromagnetic field therapy on muscle mass and muscle strength in prostate cancer patients treated with androgen deprivation therapy |
Prof. NG Chi Fai 吳志輝 |
| 2025.343 | Development for AI-Powered Retrograde Intrarenal Surgery | Prof. NG Chi Fai |
| 2023.583 | A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma | Prof. NG Chi Fai |
| 2023.589 | Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial | Prof. NG Chi Fai |
| 2023.509 | To investigate the effect of multidisciplinary care approach on cardiovascular risk modification in prostate cancer patients receiving androgen deprivation therapy |
Prof. NG Chi Fai Chi Fai NG |
| 2024.300 | Development of a novel model to predict recurrence for clear cell renal cell carcinoma treated with nephrectomy | Prof. NG Chi Fai |
| 2025.322 | Development and validation of a new scale to assess sexual problems in people with prostate cancer and to design an electronic patient-reported outcome measure for this population (ePROM-SexPCare) | Prof. NG Chi Fai |
| 2024.518 | The prevalence, severity and predictors of sleep disorders and their dyadic effects on the mutual relationships, quality of life, fatigue, anxiety and depression of adult male patients with prostate and colorectal cancers undergoing active treatment and their partners in Hong Kong: A mixed-methods study | Prof. NG Chi Fai |
| 2024.511 | Effects of creative arts therapy on body image, self-esteem, anxiety and depression in men with prostate cancer after active treatment: A feasibility randomised controlled trial | Prof. NG Chi Fai |
| 2024.114 | Surveys to investigate injection site complications and pain related to androgen deprivation therapies in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2024.387 | Using Real-world Big Data to Reveal the Associations between Coexisting Chronic Diseases, Medications, and Cancer | Prof. NG Chi Fai |
| 2025.517 | Kidney stone incidence in patients with osteoporosis undergoing bisphosphonates or denosumab treatment | Prof. NG Chi Fai |
| 2016.428 | A Multi-Center, International Registry to evaluate the treatment of Upper Tract Urothelial Cancer: Incidence, Indications, Treatment types and Outcomes. |
Dr. NG Chi Fai 吳志輝 |
| 2016.508 | Understanding the role of purinergic signalling in the human bladder |
Dr. NG Chi Fai 吳志輝 |
| 2014.467 | Urinary metabolic prognostic markers in prostate cancer | Prof. NG Chi Fai |
| 2016.105 | A retrospective review of the clinical and pathological outcome of patients receiving transrectal ultrasound with prostate biopsy in Hong Kong |
Dr. NG Chi Fai 吳志輝 |
Page 90 of 268.